Key points are not available for this paper at this time.
At a temperature of 100 K, CH5N2+·I- (I), crystallizes in the monoclinic space group P21/c. The formamidinium cation adopts a planar symmetrical structure the r.m.s. deviation is 0.002 Å, and the C-N bond lengths are 1.301 (7) and 1.309 (8) Å. The iodide anion does not lie within the cation plane, but deviates from it by 0.643 (10) Å. The cation and anion of I form a tight ionic pair by a strong N-H⋯I hydrogen bond. In the crystal of I, the tight ionic pairs form hydrogen-bonded zigzag-like chains propagating toward 20-1 via strong N-H⋯I hydrogen bonds. The hydrogen-bonded chains are further packed in stacks along 100. The thermal behaviour of I was studied by different physicochemical methods (thermogravimetry, differential scanning calorimetry and powder diffraction). Differential scanning calorimetry revealed three narrow endothermic peaks at 346, 387 and 525 K, and one broad endothermic peak at ∼605 K. The first and second peaks are related to solid-solid phase transitions, while the third and fourth peaks are attributed to the melting and decomposition of I. The enthalpies of the phase transitions at 346 and 387 K are estimated as 2.60 and 2.75 kJ mol-1, respectively. The X-ray powder diffraction data collected at different temperatures indicate the existence of I as the monoclinic (100-346 K), ortho-rhom-bic (346-387 K) and cubic (387-525 K) polymorphic modifications.
Petrov et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: